Publikationen, an denen er mitarbeitet Joaquim Bosch Barrera (11)

2022

  1. Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors

    Cancers, Vol. 14, Núm. 24

2020

  1. Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

    Aging, Vol. 12, Núm. 21, pp. 21057-21075

2019

  1. An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors

    Carcinogenesis, Vol. 40, Núm. 1, pp. 27-40

  2. Computational de-orphanization of the olive oil biophenol oleacein: Discovery of new metabolic and epigenetic targets

    Food and Chemical Toxicology, Vol. 131

  3. Extra virgin olive oil contains a phenolic inhibitor of the histone demethylase LSD1/KDM1A

    Nutrients, Vol. 11, Núm. 7

  4. The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase

    Food and Chemical Toxicology, Vol. 128, pp. 35-45

2014

  1. Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment

    Oncotarget, Vol. 5, Núm. 9, pp. 2344-2348

2013

  1. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells

    Food and Chemical Toxicology, Vol. 60, pp. 360-368

  2. Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo

    Scientific Reports, Vol. 3

  3. Stem cell-like ALDHbright cellular states in EGFR-mutant non-small cell lung cancer a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin

    Cell Cycle, Vol. 12, Núm. 21, pp. 3390-3404

2012

  1. Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205

    Cell Cycle, Vol. 11, Núm. 6, pp. 1235-1246